quantitative
Analysis v1
Strong Support

People with knee arthritis and type 2 diabetes who take GLP-1 drugs like Ozempic might lose knee cartilage more slowly, which could help delay joint damage.

67
Pro
0
Against

Evidence from Studies

Supporting (1)

67

Community contributions welcome

The study looked at people with knee arthritis and diabetes who took GLP-1 receptor agonists and found their knee cartilage wore away more slowly, just like the claim says.

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.